Nucleotide encoding human galanin receptor 3 (GALR3)

US6511827B1 · kind B1 · utility

Assignee

• MERCK & CO., INC. · US

Inventors

• Andrew D. Howard · Park Ridge, US
• Margaret A. Cascieri · Plainsboro, US
• Roy G. Smith · Houston, US
• Kathleen Sullivan · Cooperstown, US
• Carina Tan · Metuchen, US
• Leonardus H. T. Van Der Ploeg · Newton, US
• Kevin R. Lynch · Charlottesville, US

Key dates

• Filing date: Jun 16, 2000
• Grant date: Jan 28, 2003
• Expiry date: Jun 16, 2020

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K38/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A new galanin receptor, GALR3, is described. Also provided are nucleic acids encoding same and various assays to identify ligands particular to said receptor. Ligands so identified are useful for the treatment of obesity, treatment of pain, and treatment of cognitive disorders.